A Lack of COVID Testing May Increase Risky Behavior, Survey Shows
A new study found that when COVID-19 testing wasn’t readily available, participants showed significantly greater intentions to engage in risky behavior.
Read MorePosted by Andy Lundin | Feb 11, 2022 | Covid 19, POC Reagents & Test Kits |
A new study found that when COVID-19 testing wasn’t readily available, participants showed significantly greater intentions to engage in risky behavior.
Read MorePosted by Andy Lundin | Feb 10, 2022 | Covid 19, Immunoassay Reagents & test Kits |
Avellino Lab USA launched a multi-panel RT-PCR-based virus assay that can detect COVID-19, respiratory syncytial virus (RSV), influenza A, and influenza B.
Read MorePosted by Andy Lundin | Jan 31, 2022 | Cancer, Point-of-Care |
The detection and quantification of cancer-associated molecular biomarkers in body fluids prove minimally invasive in early cancer diagnostics.
Read MorePosted by Andy Lundin | Jan 28, 2022 | Covid 19, Immunoassay Reagents & test Kits |
The ClearDetect COVID-19 Antigen Home Test (ClearDetect) which received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration.
Read MorePosted by Andy Lundin | Jan 28, 2022 | Covid 19, Immunoassay Reagents & test Kits |
The new service features proctored telehealth by which a technician observes proper sample collection, confirms identity, and certifies results reporting.
Read More